跳到主要內容

Sepp-Lorenzino Laura 的 Form 4 申報

Intellia Therapeutics, Inc.(NTLA),2021/8/6 申報

申報編號
0001209191-21-050228
申報時間
2021/8/6
交易日
2021/8/4
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 8 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $359.4 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Sepp-Lorenzino LauraCIK 0001777421高階主管(執行副總裁、科學長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/8/4Common StockM行使選擇權取得+26,000$13.40+$348,40028,391直接
2021/8/4Common StockS賣出處分−1,471$135.47F2−$199,276.3726,920直接
2021/8/4Common StockS賣出處分−6,814$136.79F3−$932,087.0620,106直接
2021/8/4Common StockS賣出處分−6,344$137.72F4−$873,695.6813,762直接
2021/8/4Common StockS賣出處分−4,419$138.78F5−$613,268.829,343直接
2021/8/4Common StockS賣出處分−2,772$139.85F6−$387,664.26,571直接
2021/8/4Common StockS賣出處分−4,054$140.73F7−$570,519.422,517直接
2021/8/4Common StockS賣出處分−126$141.63−$17,845.382,391直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2021/8/4Common StockM行使選擇權處分−26,000$0.00$0109,000直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.18 to $135.885, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.25 to $137.24, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.255 to $138.25, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.31 to $139.305, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.395 to $140.37, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.395 to $141.04, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 4, 2021 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)